Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study-Reference-Cited by-同舟云学术

Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study

Published:2020-05 Issue: Volume:135 Page:34-39
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Di Donato Violante,D’Oria Ottavia,Scudo Maria,Prata Giovanni,Fischetti Margherita,Lecce Francesca,Schiavi Michele Carlo,Giannini Andrea,Muzii Ludovico,Battaglia Francesco,Monti Marco,Benedetti Panici Pierluigi

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference19 articles.

1. Urogenital atrophy;Calleja-Agius;Climacteric,2009

2. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes;Sokol;Menopause,2017

3. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (Real Women’s Views of Treatment Options for Menopausal Vaginal Changes) survey;Kingberg;J. Sex. Med.,2013

4. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy;Sokol;Menopause,2016

5. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser;Perino;Maturitas,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Genitourinary Syndrome Associated with Dyspareunia with Laser Therapy;Laser Therapy in Healthcare;2024-07-03

2. The Use of Carbon Dioxide (Co2) Lasers in the Treatment of Vulvovaginal Atrophy Symptoms in Perimenopausal and Postmenopausal Women;Journal of Innovative Healthcare Practices;2024-03-28

3. Female sexual function index for screening of female sexual dysfunction using DSM-5-TR criteria in Thai women: A prospective cross-sectional diagnostic study;PLOS ONE;2024-02-22

4. Real‑world performance and safety of vaginal ovules in reducing the vaginal symptoms associated with vulvovaginal atrophy and postmenopausal sexual dysfunction;Biomedical Reports;2024-01-09

5. Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis;Clinical Breast Cancer;2023-12